artificial intelligence

By Dave Muoio 02:56 pm May 14, 2020
Artificial intelligence is knocking on the healthcare industry's doors. From computation-driven R&D for new drugs, to objective image analysis, to mass-scale disease screening and diagnosis, more and more instances of the technology are pitching solutions to some of the industry's most pressing challenges. Regulators once stood as the primary hurdle for AI and associated technologies like...
By Bradley Merrill Thompson 03:46 pm April 24, 2020
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug and combination product companies on a wide range of FDA regulatory, reimbursement and clinical trial issues. The opinions in this piece are Thompson's and don't necessarily reflect the opinions of MobiHealthNews or HIMSS. Many appreciate that telemedicine...
Health robot illustration
Sponsored by
By PsychU 03:02 pm April 7, 2020
A group of organizations—Amazon, Apple, and Google among others—are blurring the line between the tech field and the healthcare field. One of the key elements in this blurring of the line is the automation of health and human service functions that previously required human work. This tech-enabled automation is frequently accomplished through bots, which are computer applications that perform...
By Dave Muoio 03:01 pm March 31, 2020
Olive, an artificial intelligence company tackling healthcare administration tasks, has closed $51 million in a funding round led by General Catalyst. Also participating in the raise were the company's existing backers Drive Capital, Oak HC/FT, Ascension Ventures and other unnamed investors. WHAT THEY DO Olive's "AI Workforce" is designed to automate a selection of tedious, high-volume...
By Dave Muoio 03:40 pm March 18, 2020
A collaboration between government organizations, research institutions and major tech companies has put out the call for artificial intelligence experts interested in generating new insights about coronavirus. As of Monday, a collection of machine-readable literature on the coronavirus group of viruses is now freely available for review on the Allen Institute for AI's SemanticScholar.org website...
By Dave Muoio 03:26 pm March 5, 2020
SymphonyAI Group, a collection of private B2B artificial intelligence companies spanning multiple sectors, announced yesterday that it has acquired TeraRecon, the maker of products for medical-image post-processing and other related products. As the group’s seventh portfolio company, TeraRecon will continue building out its radiology, cardiology and vascular-surgery AI-imaging support. However,...

Above photo: A doctor in SPHCC using the Intelligent Evaluation System of Chest CT for COVID-19 for accurate diagnosis. Credit: Business Wire

By Dean Koh 01:10 am February 21, 2020
Since the outbreak of COVID-19 virus in China, Shanghai Public Health Clinical Center (SPHCC) has been actively mobilizing other parties to use the latest tech in the fight against the virus. Through the joint effort of SPHCC and Yitu Healthcare, a Shanghai-based AI startup, the Intelligent Evaluation System of Chest CT for COVID-19 was officially launched on 28 January.  HOW IT WORKS The system...

Credit: IHiS

By Dean Koh 04:17 am February 14, 2020
Integrated Health Information Systems (IHiS), the national HIT agency in Singapore, has partnered with local healthcare AI startup KroniKare to pilot iThermo – an AI-powered temperature screening solution that screens and identifies those having or showing symptoms of fever. iThermo is currently being piloted at IHiS headquarters in Serangoon North and St. Andrews Community Hospital (SACH) from...
By Anish Sebastian 11:50 am January 3, 2020
About the author: Anish Sebastian co-founded Babyscripts in 2013, which has partnered with dozens of health systems for its data-centric model in prenatal care. As the CEO of the startup, Anish has focused his efforts on product and software development, as well as evidence-based validation of their product. Prior to this, he founded a research analytics startup and served as a senior tech...
By Dave Muoio 03:28 pm December 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. WHAT THEY DO OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...